- Therapeutics, therapeutic target and preclinical evaluation
- Environmental stressors in health
- Bioinformatics in gene networks and therapeutics assessment
- Genetic base of diseases
UCL Queen Square Institute of Neurology, United Kingdom
Erasmus University Medical Center (EMC), Rotterdam, The Netherlands + Faculty of Medicine, KU Leuven, Belgium
Gene Center and Center for Innovative Medical Models (CiMM), LMU Munich, Germany
- Monica Ballarino, Italy
- Jana Balounova, Czech Republic
- Peter Draber, Czech Republic
- Andrzej Dziembowski, Poland
- Dominik Filipp, Czech Republic
- Liesbet Geris, Belgium
- Yann Herault, France
- Karol Kaiser, Switzerland
- Pavel Krejci, Czech Republic
- Eva Kudova, Czech Republic
- Radim Nencka, Czech Republic
- Marek Ostaszewski, Luxembourg
- Jakub Rohlena, Czech Republic
- Ondrej Stepanek, Czech Republic
- Tomas Stopka, Czech Republic
It is my great pleasure to invite you to the second CCP Phenogenomics Conference. The conference is divided into two blocks. The first day will be devoted to the theme “From chemistry via preclinical pipeline to therapeutics“, which emphasizes the translation of the basic research into the application. A wide range of speakers from medical chemistry, environmental toxicology, bioinformatics, animal model development, and preclinical testing will gather to boost clustering in the area of preclinical evaluation in the Czech Republic and Europe.
The second day is specifically devoted to CCP’s users and cooperation partners working in the field of immunology, hematology, genetic base of diseases, and neurobiology.
The Conference will provide an excellent opportunity to support networking and interactions among the stakeholders in preclinical research and CCP users. We are looking forward to meeting you in September 2020.
Director of the Czech Centre for Phenogenomics
Institute of Molecular Genetics of the Czech Academy of Sciences
Czech Centre for Phenogenomics (CCP)
CCP is a large research infrastructure unique in combining genetic engineering capabilities, advanced phenotyping and imaging modalities, SPF animal housing and husbandry, as well as cryopreservation and archiving, all in one central location – at BIOCEV campus.
Through its membership in INFRAFRONTIER and IMPC, CCP is a partner in a global network that aims to comprehensively and systematically analyze the effect of loss of function gene mutations in mice. The goal is to produce a comprehensive ‘encyclopedia‘ of gene function, that will help identify causative factors of human diseases as well as novel targets for therapeutic intervention.